MARKET

ALIM

ALIM

Alimera Sciences
NASDAQ
3.520
-0.330
-8.57%
Closed 16:00 04/12 EDT
OPEN
3.800
PREV CLOSE
3.850
HIGH
3.830
LOW
3.475
VOLUME
56.09K
TURNOVER
0
52 WEEK HIGH
4.380
52 WEEK LOW
1.560
MARKET CAP
184.29M
P/E (TTM)
-4.2065
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ALIM last week (0401-0405)?
Weekly Report · 5d ago
Weekly Report: what happened at ALIM last week (0325-0329)?
Weekly Report · 04/01 11:32
Alimera Sciences Price Target Announced at $10.00/Share by Maxim Group
Dow Jones · 03/25 12:14
Alimera Sciences Initiated at Buy by Maxim Group
Dow Jones · 03/25 12:14
Maxim Group Initiates Coverage On Alimera Sciences with Buy Rating, Announces Price Target of $10
Benzinga · 03/25 12:03
Weekly Report: what happened at ALIM last week (0318-0322)?
Weekly Report · 03/25 11:35
The top stocks with buying pressure across the Russell universe - Jefferies
The top stocks with buying pressure across the Russell universe. Jefferies analysts highlighted names in the FTSE Russell indices with the biggest buying pressures on the passive side. These are the top 10 buys for passive investors by dollars and the top ten buys by days to trade, based on trading volume over the last 10 days.
Seeking Alpha · 03/20 15:40
Weekly Report: what happened at ALIM last week (0311-0315)?
Weekly Report · 03/18 11:33
More
About ALIM
Alimera Sciences, Inc. is a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic retinal pharmaceuticals. It is engaged in developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the United States for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients to maintain vision longer, and importantly, with fewer injections. ILUVIEN is an intravitreal implant that treats patients by delivering a continuous micro dose of the corticosteroid fluocinolone acetonide (FAc) in the eye, for up to 36 months. ILUVIEN is inserted into the back of the patient's eye in a non-surgical procedure employing a device with a 25-gauge needle, which allows for a self-sealing wound. DME is also treated by laser photocoagulation, a retinal procedure in which a laser is used to apply a burn.

Webull offers Alimera Sciences Inc stock information, including NASDAQ: ALIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALIM stock methods without spending real money on the virtual paper trading platform.